Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.2, 2001-02, pp. : 277-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense oligonucleotides: local delivery enhances their therapeutic potential

By Nyce J.W.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 3, 1999-03 ,pp. : 263-267

Informa Healthcare

Access to resources Recommend Favorite

Respirable antisense oligonucleotides as novel therapeutic agents for asthma and other pulmonary diseases

By Nyce J.W.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1149-1156

Informa Healthcare

Access to resources Recommend Favorite

Antisense Oligonucleotides As Therapeutic Agents

By Alama A. Barbieri F. Cagnoli M. Schettini G.

Pharmacological Research, Vol. 36, Iss. 3, 1997-09 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite

Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other Diseases

Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-11 ,pp. : 211-230

Bentham Science Publishers

Access to resources Recommend Favorite

Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases

Current Drug Targets, Vol. 6, Iss. 1, 2005-02 ,pp. : 21-29

Bentham Science Publishers

Access to resources Recommend Favorite